Literature DB >> 34071938

Clinical Significance of Tumor Infiltrating Lymphocytes in Association with Hormone Receptor Expression Patterns in Epithelial Ovarian Cancer.

Gwan Hee Han1,2, Ilseon Hwang3,4, Hanbyoul Cho1,3,5,6, Kris Ylaya3, Jung-A Choi5, Hyunja Kwon5, Joon-Yong Chung3, Stephen M Hewitt3, Jae-Hoon Kim1,5,6.   

Abstract

Hormone receptor expression patterns often correlate with infiltration of specific lymphocytes in tumors. Specifically, the presence of specific tumor-infiltrating lymphocytes (TILs) with particular hormone receptor expression is reportedly associated with breast cancer, however, this has not been revealed in epithelial ovarian cancer (EOC). Therefore, we investigated the association between hormone receptor expression and TILs in EOC. Here we found that ERα, AR, and GR expression increased in EOC, while PR was significantly reduced and ERβ expression showed a reduced trend compared to normal epithelium. Cluster analysis indicated poor disease-free survival (DFS) in AR+/GR+/PR+ subgroup (triple dominant group); while the Cox proportional-hazards model highlighted the triple dominant group as an independent prognostic factor for DFS. In addition, significant upregulation of FoxP3+ TILs, PD-1, and PD-L1 was observed in the triple dominant group compared to other groups. NanoString analyses further suggested that tumor necrosis factor (TNF) and/or NF-κB signaling pathways were activated with significant upregulation of RELA, MAP3K5, TNFAIP3, BCL2L1, RIPK1, TRAF2, PARP1, and AKT1 in the triple dominant EOC group. The triple dominant subgroup correlates with poor prognosis in EOC. Moreover, the TNF and/or NF-κB signaling pathways may be responsible for hormone-mediated inhibition of the immune microenvironment.

Entities:  

Keywords:  epithelial ovarian cancer; hormone receptors; regulatory T cell; triple dominant group; tumor infiltrating lymphocytes

Year:  2021        PMID: 34071938     DOI: 10.3390/ijms22115714

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  44 in total

Review 1.  Toll-like receptors on regulatory T cells: expanding immune regulation.

Authors:  Roger P M Sutmuller; Mary E Morgan; Mihai G Netea; Oliver Grauer; Gosse J Adema
Journal:  Trends Immunol       Date:  2006-06-30       Impact factor: 16.687

2.  Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors.

Authors:  Hugo Arias-Pulido; Harriet O Smith; Nancy E Joste; Therese Bocklage; Clifford R Qualls; Allison Chavez; Eric R Prossnitz; Claire F Verschraegen
Journal:  Gynecol Oncol       Date:  2009-06-27       Impact factor: 5.482

3.  The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

Authors:  R Salgado; C Denkert; S Demaria; N Sirtaine; F Klauschen; G Pruneri; S Wienert; G Van den Eynden; F L Baehner; F Penault-Llorca; E A Perez; E A Thompson; W F Symmans; A L Richardson; J Brock; C Criscitiello; H Bailey; M Ignatiadis; G Floris; J Sparano; Z Kos; T Nielsen; D L Rimm; K H Allison; J S Reis-Filho; S Loibl; C Sotiriou; G Viale; S Badve; S Adams; K Willard-Gallo; S Loi
Journal:  Ann Oncol       Date:  2014-09-11       Impact factor: 32.976

Review 4.  Crosstalk between NFkB and glucocorticoid signaling: a potential target of breast cancer therapy.

Authors:  Jun Ling; Raj Kumar
Journal:  Cancer Lett       Date:  2012-03-17       Impact factor: 8.679

Review 5.  Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification.

Authors:  Danielle Duma; Christine M Jewell; John A Cidlowski
Journal:  J Steroid Biochem Mol Biol       Date:  2006-10-27       Impact factor: 4.292

6.  High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia.

Authors:  Yu Hou; Qi Feng; Miao Xu; Guo-Sheng Li; Xue-Na Liu; Zi Sheng; Hai Zhou; Ji Ma; Yu Wei; Yuan-Xin Sun; Ying-Yi Yu; Ji-Hua Qiu; Lin-Lin Shao; Xin-Guang Liu; Ming Hou; Jun Peng
Journal:  Blood       Date:  2016-01-07       Impact factor: 22.113

7.  Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.

Authors:  Jonna Frasor; Aisha Weaver; Madhumita Pradhan; Yang Dai; Lance D Miller; Chin-Yo Lin; Adina Stanculescu
Journal:  Cancer Res       Date:  2009-11-17       Impact factor: 12.701

8.  GILZ promotes production of peripherally induced Treg cells and mediates the crosstalk between glucocorticoids and TGF-β signaling.

Authors:  Oxana Bereshchenko; Maddalena Coppo; Stefano Bruscoli; Michele Biagioli; Monica Cimino; Tiziana Frammartino; Daniele Sorcini; Alessandra Venanzi; Moises Di Sante; Carlo Riccardi
Journal:  Cell Rep       Date:  2014-04-03       Impact factor: 9.423

9.  Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse.

Authors:  Gaynor J Bates; Stephen B Fox; Cheng Han; Russell D Leek; José F Garcia; Adrian L Harris; Alison H Banham
Journal:  J Clin Oncol       Date:  2006-12-01       Impact factor: 44.544

Review 10.  The environment of regulatory T cell biology: cytokines, metabolites, and the microbiome.

Authors:  Romy E Hoeppli; Dan Wu; Laura Cook; Megan K Levings
Journal:  Front Immunol       Date:  2015-02-18       Impact factor: 7.561

View more
  2 in total

Review 1.  Etiopathogenesis of ovarian cancer. An inflamm-aging entity?

Authors:  Manuel Sánchez-Prieto; Rafael Sánchez-Borrego; Daniel Maria Lubián-López; Faustino R Pérez-López
Journal:  Gynecol Oncol Rep       Date:  2022-06-11

2.  NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells.

Authors:  Hee Yun; Gwan Hee Han; Julie Kim; Joon-Yong Chung; Jae-Hoon Kim; Hanbyoul Cho
Journal:  J Cell Mol Med       Date:  2022-09-16       Impact factor: 5.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.